» Articles » PMID: 34440265

Exosomes: Potential Disease Biomarkers and New Therapeutic Targets

Overview
Journal Biomedicines
Date 2021 Aug 27
PMID 34440265
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes are extracellular vesicles released by cells, both constitutively and after cell activation, and are present in different types of biological fluid. Exosomes are involved in the pathogenesis of diseases, such as cancer, neurodegenerative diseases, pregnancy disorders and cardiovascular diseases, and have emerged as potential non-invasive biomarkers for the detection, prognosis and therapeutics of a myriad of diseases. In this review, we describe recent advances related to the regulatory mechanisms of exosome biogenesis, release and molecular composition, as well as their role in health and disease, and their potential use as disease biomarkers and therapeutic targets. In addition, the advantages and disadvantages of their main isolation methods, characterization and cargo analysis, as well as the experimental methods used for exosome-mediated drug delivery, are discussed. Finally, we present potential perspectives for the use of exosomes in future clinical practice.

Citing Articles

An anti-CD19-exosome delivery system navigates the blood-brain barrier for targeting of central nervous system lymphoma.

Zhao M, Li Q, Chai Y, Rong R, He L, Zhang Y J Nanobiotechnology. 2025; 23(1):173.

PMID: 40045315 PMC: 11881385. DOI: 10.1186/s12951-025-03238-9.


Review of mesenchymal stem cell-derived exosomes and their potential therapeutic roles in treating rheumatoid arthritis.

Aghajani S, Maboudi S, Seyhoun I, Nia R, Shabestari A, Sharif S Mol Biol Rep. 2025; 52(1):229.

PMID: 39948229 DOI: 10.1007/s11033-025-10290-z.


Menopause mysteries: the exosome-inflammation connection.

Sultania A, Brahadeeswaran S, Kolasseri A, Jayanthi S, Tamizhselvi R J Ovarian Res. 2025; 18(1):12.

PMID: 39849635 PMC: 11756133. DOI: 10.1186/s13048-025-01591-9.


Extracellular Vesicles: Advanced Tools for Disease Diagnosis, Monitoring, and Therapies.

Lorite P, Dominguez J, Palomeque T, Torres M Int J Mol Sci. 2025; 26(1.

PMID: 39796048 PMC: 11720073. DOI: 10.3390/ijms26010189.


Exosomes and miRNAs in Cardiovascular Diseases and Transcatheter Pulmonary Valve Replacement: Advancements, Gaps and Perspectives.

Liang R, Abudurexiti N, Wu J, Ling J, Peng Z, Yuan H Int J Mol Sci. 2025; 25(24.

PMID: 39769447 PMC: 11727898. DOI: 10.3390/ijms252413686.


References
1.
Holder B, Jones T, Sancho Shimizu V, Rice T, Donaldson B, Bouqueau M . Macrophage Exosomes Induce Placental Inflammatory Cytokines: A Novel Mode of Maternal-Placental Messaging. Traffic. 2015; 17(2):168-78. PMC: 4738478. DOI: 10.1111/tra.12352. View

2.
van Niel G, Wubbolts R, Ten Broeke T, Buschow S, Ossendorp F, Melief C . Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. Immunity. 2006; 25(6):885-94. DOI: 10.1016/j.immuni.2006.11.001. View

3.
Cheng Z, Wang L, Wu C, Huang L, Ruan Y, Xue W . Tumor-derived Exosomes Induced M2 Macrophage Polarization and Promoted the Metastasis of Osteosarcoma Cells Through Tim-3. Arch Med Res. 2020; 52(2):200-210. DOI: 10.1016/j.arcmed.2020.10.018. View

4.
Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View

5.
Qiu P, Zhou J, Zhang J, Dong Y, Liu Y . Exosome: The Regulator of the Immune System in Sepsis. Front Pharmacol. 2021; 12:671164. PMC: 8113812. DOI: 10.3389/fphar.2021.671164. View